Clinical Trial Update: Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial (ReMEDy2) evaluating DM199 for acute ischemic stroke is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DM199

Snippet

Sponsor: DiaMedica Therapeutics Inc | Conditions: Acute Stroke, Ischemic Stroke | Phase 2, Phase 3 | Status: RECRUITING